Acorda Says It's Owed $65M More In MS Drug Fight
Acorda Therapeutics Inc. has told a New York federal court that an arbitral tribunal got it wrong when it awarded the company only $16 million in a royalties dispute with an...To view the full article, register now.
Already a subscriber? Click here to view full article